Your browser doesn't support javascript.
loading
Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study.
Davarpanah, M A; Adatorwovor, R; Mansoori, Y; Ramsheh, F S R; Parsa, A; Hajiani, M; Faramarzi, H; Kavuluru, R; Asadipooya, K.
Afiliación
  • Davarpanah MA; Shiraz HIV/AIDS Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Adatorwovor R; Department of Biostatistics, University of Kentucky, Lexington, KY, USA.
  • Mansoori Y; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Ramsheh FSR; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Parsa A; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Hajiani M; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Faramarzi H; Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Kavuluru R; Division of Biomedical Informatics, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.
  • Asadipooya K; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Barnstable Brown Diabetes and Obesity Center, University of Kentucky, 2195 Harrodsburg Rd, Suite 125, Lexington, KY, 40504, USA. kas224@uky.edu.
J Endocrinol Invest ; 47(1): 235-243, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37354247

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfato de Sitagliptina / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2024 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfato de Sitagliptina / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2024 Tipo del documento: Article País de afiliación: Irán